UNIGE document Scientific Article
previous document  unige:1146  next document
add to browser collection

Differential roles of endothelin-1 ETA and ETB receptors and vasoactive intestinal polypeptide in regulation of the airways and the pulmonary vasculature in isolated rat lung

Published in Experimental Physiology. 2008, vol. 93, no. 11, p. 1210-9
Abstract The available treatment strategies against pulmonary hypertension include the administration of endothelin-1 (ET-1) receptor subtype blockers (ET(A) and ET(B) antagonists); vasoactive intestinal polypeptide (VIP) has recently been suggested as a potential new therapeutic agent. We set out to investigate the ability of these agents to protect against the vasoconstriction and impairment of lung function commonly observed in patients with pulmonary hypertension. An ET(A) blocker (BQ123), ET(B) blocker (BQ788), a combination of these selective blockers (ET(A) + ET(B) blockers) or VIP (V6130) was administered into the pulmonary circulation in four groups of perfused normal rat lungs. Pulmonary vascular resistance (PVR) and forced oscillatory lung input impedance (Z(L)) were measured in all groups under baseline conditions and at 1 min intervals following ET-1 administrations. The airway resistance, inertance, tissue damping and elastance were extracted from the Z(L) spectra. While VIP, ET(A) blocker and combined ET(A) and ET(B) blockers significantly prevented the pulmonary vasoconstriction induced by ET-1, ET(B) blockade enhanced the ET-1-induced increases in PVR. In contrast, the ET(A) and ET(B) blockers markedly elevated the ET-1-induced increases in airway resistance, while VIP blunted this constrictor response. Our results suggest that VIP potently acts against the airway and pulmonary vascular constriction mediated by endothelin-1, while the ET(A) and ET(B) blockers exert a differential effect between airway resistance and PVR.
Keywords Airway Resistance/drug effectsAnimalsAntihypertensive Agents/pharmacologyBronchoconstriction/drug effectsEndothelin-1/metabolismHypertension, Pulmonary/drug therapy/metabolism/physiopathologyLung/blood supply/drug effects/metabolismLung Compliance/drug effectsMaleOligopeptides/pharmacologyPeptides, Cyclic/pharmacologyPiperidines/pharmacologyPulmonary Circulation/drug effectsRatsRats, Sprague-DawleyReceptor, Endothelin A/antagonists & inhibitors/metabolismReceptor, Endothelin B/antagonists & inhibitors/metabolismRespiratory Mechanics/drug effectsVascular Resistance/drug effectsVasoactive Intestinal Peptide/pharmacologyVasoconstriction/drug effects
Stable URL http://archive-ouverte.unige.ch/unige:1146
Full text
PMID: 18567602
Research groups L'hypertension pulmonaire (pédiatrie) (228)
Enfants et hyperréactivité bronchique (69)
131 hits and 1 download since 2009-03-13
Export document
Format :
Citation style :